A Multi Organ Involvement due to COVID-19: A Study Report

Abstract

SARS-CoV-2, a new coronavirus strain, first appeared in China in November 2019 and has since spread to
over 150 countries. SARS-CoV-2 not only causes pneumonia, but it also has the potential to affect other
organs such as the heart, liver, and kidneys. The role of the lungs, kidneys, and heart in COVID 19, as well
as the mechanism of lung, kidney, and heart damage and its influence on mortality, are discussed here. In
late 2019, coronavirus-2, a significant human infection that causes the disease coronavirus disease in 2019,
appeared as a major human pathogen (COVID-19). Acute respiratory failure, which is similar to the acute
respiratory distress syndrome ARDS, is the most prevalent clinical manifestation of severe COVID-19.
COVID-19 includes diseases of the airway, lung parenchymal, pulmonary vascular, and respiratory
neuromuscular systems. The consequences of severe acute respiratory syndrome coronavirus-2 infection
are discussed in this article. COVID-19 has the potential to have a major impact on the cardiovascular
systems of individuals. For starters, those who have COVID-19 and prior cardiovascular disease are at a
higher risk of developing severe illness and dying. COVID-19-related mortality is highly linked to
cardiovascular disease, diabetes, and hypertension. Second, medications being tested for COVID-19 might
cause arrhythmia in the cardiovascular system. Finally, COVID-19 has been linked to a variety of direct
and indirect cardiovascular problems.